Supplemental Methods, Figures 1 - 4 from Retargeting T Cells to GD2 Pentasaccharide on Human Tumors Using Bispecific Humanized Antibody

Authors :: Nai-Kong V. Cheung
Morgan Huse
Yuedan Chen
Hongfen Guo
Ming Cheng
Hong Xu
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Supplemental Figure S1: Tumor free survival in humanized DKO mice. Supplemental Figure S2: T cell survival in the sc tumors. Supplemental Figure S3: Efficacy of hu3F8-BsAb vs. 5HLDS(15)BA(Y) in humanized DKO mice. Supplemental Figure S4: Cytokine release from different BsAb formats.

Tools